Statin lipid-lowering drugs and bone mineral density

Pharmacoepidemiology and Drug Safety
Daniel H SolomonJerry Avorn

Abstract

HMG Co-A reductase inhibitors (statin lipid-lowering drugs) have been associated with a reduced rate of fractures in some studies, but not in others. We examined the relationship between statin use and bone density among postmenopausal women. We conducted a cross-sectional survey at one academic medical center. Postmenopausal women who underwent bone densitometry and agreed to a telephone interview were surveyed about osteoporosis risk factors, use of hormone replacement therapy and osteoporosis medications and statin exposure. We then developed linear regression models adjusting for known counfounders to assess the relationship between statin use and bone mineral density (BMD). Of 339 women studied, 162 were current or past users of statins, and 177 were not. Statin users and non-users were similar with respect to age, race, prior fracture history, the presence of medical conditions associated with osteoporosis, use of medications for osteoporosis, use of tobacco and use of oral glucocorticoids. Statin users had significantly higher body mass index (BMI) and rates of thiazide use, and were more likely to abstain from alcohol. After adjusting for important confounders, we found that statin use was associated with a significantl...Continue Reading

References

Oct 6, 1999·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R G RussellH A Fleisch
Jun 24, 2000·JAMA : the Journal of the American Medical Association·C R MeierH Jick
Jun 24, 2000·JAMA : the Journal of the American Medical Association·P S WangJ Avorn
Jun 24, 2000·JAMA : the Journal of the American Medical Association·S R Cummings, D C Bauer
Apr 20, 2001·JAMA : the Journal of the American Medical Association·T P van StaaC Cooper
May 9, 2001·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·F CosmanR Lindsay
Mar 5, 2002·Archives of Internal Medicine·Julie A PascoUNKNOWN Geelong Osteoporosis Study
Jul 12, 2002·Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry·Holly L FunkhouserRobert A Adler
Aug 23, 2002·European Journal of Clinical Investigation·L RejnmarkL Mosekilde
Nov 7, 2002·Cell·Shu TakedaGerard Karsenty
Dec 4, 2002·Injury Prevention : Journal of the International Society for Child and Adolescent Injury Prevention·W A RayM R Griffin

❮ Previous
Next ❯

Citations

Oct 22, 2013·International Journal of Nanomedicine·I-Chun TaiMei-Ling Ho
Jan 11, 2014·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Yijia ZhangRichard A Reinhardt
Sep 24, 2008·Expert Opinion on Investigational Drugs·Quen Oak TangEleftherios Tsiridis
Jan 30, 2010·Connective Tissue Research·Masaki SugazakiHisashi Shinoda
Aug 16, 2006·The American Journal of the Medical Sciences·Manfredi Rizzo, Giovam Battista Rini
Nov 7, 2015·National Science Review·Sarita R ShahAntonios G Mikos
May 12, 2009·The Journal of Nutritional Biochemistry·Anna TrzeciakiewiczMarie-Noëlle Horcajada
Jul 16, 2009·Journal of Cellular and Molecular Medicine·Laszlo KupcsikMauro Alini
Nov 11, 2010·Annals of the New York Academy of Sciences·Aaron J WeissJeffrey I Mechanick
Jun 19, 2013·European Journal of Pharmacology·Shu-Chun ChuangMei-Ling Ho
Apr 24, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yogita K Adlakha, Neeru Saini
Nov 23, 2005·Joint, Bone, Spine : Revue Du Rhumatisme·Martin Soubrier, Christian Roux
May 11, 2006·Integrative Cancer Therapies·Mark F McCarty, Keith I Block
May 18, 2010·Menopause : the Journal of the North American Menopause Society·Jirong YueMing Yang
Jan 28, 2015·Hypertension·Giovanni Corrao, Giuseppe Mancia
Dec 21, 2018·International Journal of Molecular Sciences·Chau-Zen WangChih-Kuang Wang
Aug 30, 2007·The Journal of Clinical Endocrinology and Metabolism·Henry G BoneMichael R McClung
Feb 14, 2006·The American Journal of Clinical Nutrition·Gregory R Mundy
Jan 28, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Elvy Suhana Mohd RamliKok-Yong Chin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.